Novartis ready to sell its $2 million one time treatment of...

Novartis ready to sell its $2 million one time treatment of spinal muscular atrophy. Benitec has 6 such programs with Axovant plus its own mystery proprietary program as well as a hep B program with Merck. OPMD is a few months away. The wheels are turning.


“This marks a new era in medicine where new therapies can cure patients in a single treatment — but at a high price. Insurers and governments will need to figure out how to pay for these therapies and society will need to decide whether any drug, even lifesaving ones, are worth millions of dollars.”


“Acting FDA Commissioner Ned Sharpless lauded the approval, saying in a statement that it marked “another milestone in the transformational power of gene and cell therapies to treat a wide range of diseases. With each new approval, we see this exciting area of science continue to move beyond the concept phase into reality.”


https://www.cnbc.com/2019/05/24/fda-approves-novartis-2-million-spinal-muscular-atrophy-gene-therapy.html